Literature DB >> 59479

[Significance of metabolic parameters in Hodgkin's disease (author's transl)].

J Oertel, H Gerhartz.   

Abstract

In 56 patients with Hodgkin's disease, the following bloodtests were carried out: erythrocyte sedimentation rate (ESR), fibrinogen, alpha2-globuline, serium iron concentrations and alkaline phosphatase activity. In some patients we additionally measured alkaline leucocyte phosphatase and serum ribonuclease activity. In our series ESR, serum iron and alpha2-globuline concentrations were the most sensitive metabolic parameters. A rise in fibrinogen concentration, alkaline phosphatase and serum ribonclease activity seems to indicate extensive disease. It is not possible, however, to discern between a state of remission and stage I by means of these parameters. ESR, serum iron and alpha2-globuline concentrations might be either elevated or normal in both instances. These parameters seem important in order to distinguish between a remission or stage I on the one hand and extensive disease in stage III and IV on the other hand. Concomitant findings of ESR above 40 mmh, elevated concentrations of fibrinogen and alpha2-globuline, as well as elevated alkaline phosphatase and serum and serum ribonuclease activity mostly indicate stage III or IV.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 59479     DOI: 10.1007/bf00284006

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN: 0084-5353


  27 in total

1.  PLASMA GLYCOPROTEINS IN THE LYMPHOMAS.

Authors:  D N WHITMORE; D A KOK
Journal:  Clin Chim Acta       Date:  1963-07       Impact factor: 3.786

2.  Effect of disease states on the ribonuclease concentration of body fluids.

Authors:  A L LEVY; A ROTTINO
Journal:  Clin Chem       Date:  1960-02       Impact factor: 8.327

3.  Electrophoretic studies on the plasma proteins of patients with neoplastic disease; lymphomas and leukemia.

Authors:  M L PETERMANN; D A KARNOFSKY; K R HOGNESS
Journal:  Cancer       Date:  1948-05       Impact factor: 6.860

4.  Electrophoretic study of the blood serum from lymphogranulomatous patients.

Authors:  A ROTTINO; D SUCHOFF; K G STERN
Journal:  J Lab Clin Med       Date:  1948-05

5.  Value of serum copper measurement in lymphomas and several other malignancies.

Authors:  S H Mortazavi; A Bani-Hashemi; M Mozafari; A Raffi
Journal:  Cancer       Date:  1972-05       Impact factor: 6.860

6.  Hepatic synthesis and secretory release of plasma alpha-2 (acute phase)-globulin appearing in malignancy.

Authors:  E J Sarcione
Journal:  Cancer Res       Date:  1967-11       Impact factor: 12.701

7.  Correlation between abnormal baseline liver tests and long-term clinical course in Hodgkin's disease.

Authors:  R E Johnson; L B Thomas; S K Johnson; G S Johnston
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

8.  Abnormal blood chemistry values in Hodgkin's disease. Lack of correlation with staging of disease.

Authors:  P H Levine
Journal:  JAMA       Date:  1972-06-26       Impact factor: 56.272

9.  Significance of leukocyte alkaline phosphatase in Hodgkin's disease.

Authors:  J M Bennett; L Nathanson; A M Rutenburg
Journal:  Arch Intern Med       Date:  1968-04

10.  The serum iron level, hematocrit, sedimentation rate, and leukocyte alkaline phosphatase level in pediatric patients with Hodgkin's disease.

Authors:  N Jaffe; J M Bishop
Journal:  Cancer       Date:  1970-08       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.